Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Jounce Therapeutics Inc on Monday agreed to be acquired by privately held Concentra Biosciences for $96.46 million, while spurning a merger deal with British biotech firm Redx Pharma.... | March 27, 2023
Source: marketscreener.com